# Effect of semaglutide 2.4 mg once weekly on 10‐year type 2 diabetes risk in adults with overweight or obesity

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effect-of-semaglutide-2-4-mg-once-weekly-on-10-year-type-2-diabetes-risk-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lua Wilkinson,Thomas Holst‐Hansen,Peter Nørkjær Laursen,Anders R. Rinnov,Rachel L. Batterham,W. Timothy Garvey |
| Citations | 20 |
| DOI | 10.1002/oby.23842 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/oby.23842 |
| OpenAlex ID | https://openalex.org/W4386046264 |
| PMID | 37605636 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Thomas Holst‐Hansen](https://scholariq.org/researchers/thomas-holst-hansen/)

## Paper journal

- [Obesity](https://scholariq.org/journals/obesity/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.